Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 1/20 | 0.64 |
| ▸ | AMDHD2 | Q9Y303 | 1/20 | 0.45 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.43 |
| ▸ | IGF2R | P11717 | 4/20 | 0.41 |
| ▸ | ITPR3 | Q14573 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15725549 | 0.88 | FBP1 (0.51) | FBP1AMDHD2SMPD1IGF2R | |
| SCHEMBL898646 | 0.83 | FBP1 (0.46) | FBP1AMDHD2IGF2RITPR3 | |
| SCHEMBL898764 | 0.83 | FBP1 (0.46) | FBP1AMDHD2IGF2RITPR3 | |
| SCHEMBL15725562 | 0.83 | FBP1 (0.46) | FBP1AMDHD2IGF2R | |
| SCHEMBL897632 | 0.82 | FBP1 (0.45) | FBP1IGF2R | |
| SCHEMBL15764610 | 0.82 | FBP1 (0.45) | FBP1IGF2R | |
| SCHEMBL15631721 | 0.82 | FBP1 (0.45) | FBP1IGF2R | |
| SCHEMBL8018689 | 0.82 | FBP1 (0.45) | FBP1AMDHD2SMPD1IGF2R | |
| SCHEMBL897629 | 0.82 | FBP1 (0.45) | FBP1IGF2R | |
| SCHEMBL15764605 | 0.81 | FBP1 (0.44) | FBP1AMDHD2SMPD1ITPR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140142052-A1 | PHOSPHORYLATED POLYOLS, PYROPHOSPHATES, AND DERIVATIVES THEREOF HAVING BIOLOGICAL ACTIVITY | NORMOXYS, INC. (US) | 2014-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140142052-A1 | PHOSPHORYLATED POLYOLS, PYROPHOSPHATES, AND DERIVATIVES THEREOF HAVING BIOLOGICAL ACTIVITY | PPIP5K2, PHOSPHO1, PIK3CA | FBP1 128/4885AMDHD2 1239/4885SMPD1 669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.